Novel Immune Modulator Promising in Acute Respiratory Distress Syndrome
(MedPage Today) -- PHOENIX -- A novel exosome-based immunomodulatory agent appeared promising in speeding recovery from acute respiratory distress syndrome (ARDS), a phase IIb trial showed. The inhaled therapy substantially increased the proportion...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
